<code id='C3636C06AD'></code><style id='C3636C06AD'></style>
    • <acronym id='C3636C06AD'></acronym>
      <center id='C3636C06AD'><center id='C3636C06AD'><tfoot id='C3636C06AD'></tfoot></center><abbr id='C3636C06AD'><dir id='C3636C06AD'><tfoot id='C3636C06AD'></tfoot><noframes id='C3636C06AD'>

    • <optgroup id='C3636C06AD'><strike id='C3636C06AD'><sup id='C3636C06AD'></sup></strike><code id='C3636C06AD'></code></optgroup>
        1. <b id='C3636C06AD'><label id='C3636C06AD'><select id='C3636C06AD'><dt id='C3636C06AD'><span id='C3636C06AD'></span></dt></select></label></b><u id='C3636C06AD'></u>
          <i id='C3636C06AD'><strike id='C3636C06AD'><tt id='C3636C06AD'><pre id='C3636C06AD'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:84746
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more
          Merck to buy EyeBio, maker of eye drug, as it grows pipeline
          Merck to buy EyeBio, maker of eye drug, as it grows pipeline

          AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion,

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Scientists successfully use ultrasound imaging to map brain activity

          AdobeResearchersmayhaveanewwaytowatchthebrainpulse,thankstoanultrasoundprobeandatinywindowintheskull